Skip to main content

Table 1 General information of pancreatic cancer patients (102 cases)

From: Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2

Category

n (%)

Gender

 Male

40 (39.2)

 Female

62 (60.8)

Age (years)

 Average

61.5 ± 10.9

 Range

32-82

Chemotherapy (gemcitabine)

 Yes

30(29.4)

 No

72(70.6)

Pathology staging(AJCC 7th)

 I

10 (9.8)

 II

80 (78.5)

 III

12 (10.8)

Back to article page

Molecular Cancer

ISSN: 1476-4598